BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35931413)

  • 41. Clinical findings of Talaromyces marneffei infection among patients with anti-interferon-γ immunodeficiency: a prospective cohort study.
    Chen ZM; Li ZT; Li SQ; Guan WJ; Qiu Y; Lei ZY; Zhan YQ; Zhou H; Lin S; Wang X; Li Z; Yang F; Zeng W; Lin Y; Liu J; Zhang JQ; Ye F
    BMC Infect Dis; 2021 Jun; 21(1):587. PubMed ID: 34144700
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection.
    Wu UI; Chuang YC; Sheng WH; Sun HY; Jhong YT; Wang JY; Chang SC; Wang JT; Chen YC
    Clin Microbiol Infect; 2018 Feb; 24(2):159-165. PubMed ID: 28694201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infections.
    Chi CY; Lin CH; Ho MW; Ding JY; Huang WC; Shih HP; Yeh CF; Fung CP; Sun HY; Huang CT; Wu TS; Chang CY; Liu YM; Feng JY; Wu WK; Wang LS; Tsai CH; Ho CM; Lin HS; Chen HJ; Lin PC; Liao WC; Chen WT; Lo CC; Wang SY; Kuo CY; Lee CH; Ku CL
    Medicine (Baltimore); 2016 Jun; 95(25):e3927. PubMed ID: 27336882
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disseminated Nontuberculous Mycobacterial Infection in a Patient with Anti-IFN-γ Autoantibodies.
    Tanimizu M; Mizuno K; Hashimoto M
    Acta Med Okayama; 2017 Dec; 71(6):547-552. PubMed ID: 29276230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disseminated Mycobacterium haemophilum skeletal disease in a patient with interferon-gamma deficiency.
    Otome O; O'Reilly M; Lim L
    Intern Med J; 2015 Oct; 45(10):1073-6. PubMed ID: 26429217
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rituximab Restores IFN-γ-STAT1 Function and Ameliorates Disseminated Mycobacterium avium Infection in a Patient with Anti-Interferon-γ Autoantibody.
    Koizumi Y; Sakagami T; Nishiyama N; Hirai J; Hayashi Y; Asai N; Yamagishi Y; Kato H; Hagihara M; Sakanashi D; Suematsu H; Ogawa K; Mikamo H
    J Clin Immunol; 2017 Oct; 37(7):644-649. PubMed ID: 28779413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Morphologic Spectrum of Lymphadenopathy in Adult-onset Immunodeficiency (Anti-interferon-γ Autoantibodies).
    Thingujam B; Syue LS; Wang RC; Chen CJ; Yu SC; Chen CC; Medeiros LJ; Liao IC; Tsai JW; Chang KC
    Am J Surg Pathol; 2021 Nov; 45(11):1561-1572. PubMed ID: 34010154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disseminated Mycobacterium avium complex infection in a patient with autoantibody to interferon-gamma.
    Tanaka Y; Hori T; Ito K; Fujita T; Ishikawa T; Uchiyama T
    Intern Med; 2007; 46(13):1005-9. PubMed ID: 17603241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reactive and infective dermatoses associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibody: Sweet's syndrome and beyond.
    Chan JF; Trendell-Smith NJ; Chan JC; Hung IF; Tang BS; Cheng VC; Yeung CK; Yuen KY
    Dermatology; 2013; 226(2):157-66. PubMed ID: 23652167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection.
    Browne SK; Zaman R; Sampaio EP; Jutivorakool K; Rosen LB; Ding L; Pancholi MJ; Yang LM; Priel DL; Uzel G; Freeman AF; Hayes CE; Baxter R; Cohen SH; Holland SM
    Blood; 2012 Apr; 119(17):3933-9. PubMed ID: 22403254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Case of Disseminated Non-tuberculous Mycobacteriosis with a Skull Lesion Controlled by Resection after Exacerbation during Antimicrobial Chemotherapy in a Patient Positive for Anti-IFN-γ-neutralizing Autoantibodies.
    Chubachi K; Taima K; Ishidoya M; Tanaka Y; Kurose A; Tasaka S
    Intern Med; 2023 Dec; ():. PubMed ID: 38044155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disseminated Mycobacterium chimaera infection in a patient with adult-onset immunodeficiency syndrome: case report.
    Lin YF; Lee TF; Wu UI; Huang CF; Cheng A; Lin KY; Hung CC
    BMC Infect Dis; 2022 Aug; 22(1):665. PubMed ID: 35915436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pulmonary Mycobacterium fortuitum infection with cervical lymphadenitis in a patient carrying autoantibodies to interferon-γ.
    Suzuki K; Terada J; Sasaki Y; Kawasaki T; Naito Y; Sakurai T; Tanabe N; Tatsumi K
    Intern Med; 2014; 53(12):1361-4. PubMed ID: 24930658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Linezolid in the treatment of disseminated nontuberculous mycobacterial infection in anti-interferon-gamma autoantibody-positive patients.
    Chetchotisakd P; Anunnatsiri S
    Southeast Asian J Trop Med Public Health; 2014 Sep; 45(5):1125-31. PubMed ID: 25417515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection.
    Yoshizawa K; Aoki A; Shima K; Tanabe Y; Koya T; Hasegawa T; Kikuchi T; Sakagami T
    J Clin Immunol; 2020 Feb; 40(2):399-405. PubMed ID: 32034574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-interferon-γ autoantibody and opportunistic infections: case series and review of the literature.
    Kampitak T; Suwanpimolkul G; Browne S; Suankratay C
    Infection; 2011 Feb; 39(1):65-71. PubMed ID: 21128092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endobronchial Lesions from Disseminated Mycobacterium avium Infection in a Patient with Anti-interferon-gamma Autoantibodies.
    Mochizuka Y; Kono M; Hirama R; Oshima Y; Takeda K; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Kimura T; Sakagami T; Nakamura H
    Intern Med; 2021 Oct; 60(20):3267-3272. PubMed ID: 33896863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disseminated
    Dahl VN; Nielsen BU; Wejse CM; Marquart HV; Bay JT; von Stemann JH; Lillebaek T; Andersen AB
    IDCases; 2021; 26():e01300. PubMed ID: 34692415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review.
    Hase I; Morimoto K; Sakagami T; Ishii Y; van Ingen J
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):308-315. PubMed ID: 28633901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neutralizing Activity of Anti-interferon-γ Autoantibodies in Adult-Onset Immunodeficiency Is Associated With Their Binding Domains.
    Yasamut U; Thongkum W; Moonmuang S; Sakkhachornphop S; Chaiwarith R; Praparattanapan J; Wipasa J; Chawansuntati K; Supparatpinyo K; Lai E; Tayapiwatana C
    Front Immunol; 2019; 10():1905. PubMed ID: 31474987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.